Response to Treatment With Oral Alitretinoin in Patients With Chronic Hand Eczema That Is Refractory to Treatment With Potent Topical Corticosteroids: Experience in 15 Patients

Statistics

Original article

Respuesta al tratamiento con alitretinoína oral en eczema crónico de manos refractario al tratamiento con corticoides tópicos potentes: nuestra experiencia en 15 pacientes

I.R. Aguayo-Leiva

Corresponding author

ingridaguayo77@hotmail.com

Corresponding author.

, S. Urrutia, P. Jaén-Olasolo

Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid

Read

14373

Times
was read the article

3241

Total PDF

11132

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/j.adengl.2010.10.008

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	82	34	116
2024 November	116	58	174
2024 October	94	51	145
2024 September	106	31	137
2024 August	130	55	185
2024 July	113	27	140
2024 June	119	36	155
2024 May	143	38	181
2024 April	141	40	181
2024 March	139	29	168
2024 February	95	35	130
2024 January	149	32	181
2023 December	214	28	242
2023 November	257	37	294
2023 October	189	27	216
2023 September	154	27	181
2023 August	138	22	160
2023 July	139	50	189
2023 June	114	35	149
2023 May	192	49	241
2023 April	194	58	252
2023 March	166	42	208
2023 February	134	39	173
2023 January	121	50	171
2022 December	132	49	181
2022 November	100	39	139
2022 October	110	41	151
2022 September	70	64	134
2022 August	94	42	136
2022 July	97	56	153
2022 June	81	45	126
2022 May	150	61	211
2022 April	150	28	178
2022 March	130	63	193
2022 February	93	29	122
2022 January	103	49	152
2021 December	78	43	121
2021 November	80	43	123
2021 October	101	53	154
2021 September	82	37	119
2021 August	92	39	131
2021 July	73	34	107
2021 June	87	36	123
2021 May	70	39	109
2021 April	379	82	461
2021 March	170	26	196
2021 February	83	37	120
2021 January	72	22	94
2020 December	43	16	59
2020 November	36	24	60
2020 October	38	23	61
2020 September	33	18	51
2020 August	27	20	47
2020 July	20	16	36
2020 June	39	24	63
2020 May	33	23	56
2020 April	35	28	63
2020 March	23	18	41
2020 February	7	3	10
2020 January	0	5	5
2019 December	3	7	10
2019 November	0	7	7
2019 October	0	6	6
2019 September	7	12	19
2019 August	1	10	11
2019 July	1	13	14
2019 June	8	11	19
2019 May	2	24	26
2019 April	12	36	48
2019 March	1	14	15
2019 February	2	8	10
2019 January	3	0	3
2018 December	1	5	6
2018 November	8	0	8
2018 October	20	0	20
2018 September	8	1	9
2018 August	0	4	4
2018 July	0	2	2
2018 June	0	4	4
2018 May	0	4	4
2018 April	0	3	3
2018 March	3	2	5
2018 February	62	3	65
2018 January	73	9	82
2017 December	64	7	71
2017 November	62	0	62
2017 October	73	6	79
2017 September	97	7	104
2017 August	146	9	155
2017 July	78	7	85
2017 June	88	30	118
2017 May	82	28	110
2017 April	83	17	100
2017 March	75	27	102
2017 February	66	20	86
2017 January	62	20	82
2016 December	78	28	106
2016 November	130	31	161
2016 October	153	31	184
2016 September	117	12	129
2016 August	132	10	142
2016 July	94	12	106
2016 June	12	12	24
2016 May	8	5	13
2016 April	4	2	6
2016 March	9	8	17
2016 February	7	1	8
2016 January	19	5	24
2015 December	20	4	24
2015 November	46	4	50
2015 October	66	8	74
2015 September	52	1	53
2015 August	39	1	40
2015 July	173	18	191
2015 June	122	7	129
2015 May	128	10	138
2015 April	135	14	149
2015 March	112	4	116
2015 February	132	14	146
2015 January	109	14	123
2014 December	120	14	134
2014 November	118	18	136
2014 October	119	19	138
2014 September	97	7	104
2014 August	80	13	93
2014 July	111	18	129
2014 June	124	7	131
2014 May	108	19	127
2014 April	64	17	81
2014 March	71	16	87
2014 February	65	33	98
2014 January	70	20	90
2013 December	86	19	105
2013 November	48	31	79
2013 October	47	19	66
2013 September	19	6	25
2013 August	15	18	33
2013 July	9	16	25
2013 June	12	31	43
2013 May	13	25	38
2013 April	18	17	35
2013 March	21	11	32
2013 February	34	6	40
2013 January	87	8	95
2012 December	34	5	39
2012 November	3	4	7
2012 October	1	0	1

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter